IDEAYA Biosciences announces inducement grants under Nasdaq listing rule, Feb. 26, 2026. Commitment to targeted therapeutics.
On February 27, 2026, in South San Francisco, IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company focusing on targeted therapeutics, shared news of the Compensation Committee's decision made on February 26, 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments